Steffie E M Vonk

3PUBLICATIONS
0CO-AUTHORS
Infant and child healthInstrumental methods (excl. immunological and bioassay methods)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 13, 2025
Real-world population pharmacokinetics of tezacaftor-ivacaftor in children with cystic fibrosis: The SYM-CF study.

Steffie E M Vonk, Suzanne W J Terheggen-Lagro, Eric G Haarman

|Jun 27, 2024
Dried Blood Spot Method Development and Clinical Validation for the Analysis of Elexacaftor, Elexacaftor-M23, Tezacaftor, Tezacaftor-M1, Ivacaftor, Ivacaftor Carboxylate, and Hydroxymethyl Ivacaftor Using LC-MS/MS.

Steffie E M Vonk, Marloes van der Meer-Vos, Renate Kos

|Mar 23, 2021
Tobramycin and vestibulotoxicity: retrospective analysis of four cases.

S E M Vonk, E J M Weersink, C J Majoor

Pageof 1

Frequent Collaborators